Alnylam Pharmaceuticals | Försäljning



Sales Ändra Datum
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amgen USD 9.09B 583M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Incyte USD 1.18B 40.83M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
Moderna USD 966M 896M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.56B 386M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Sanofi EUR 11.26B 3.5B 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Takeda JPY 1.14T 40B 2024-12
Tectonic Therapeutic 0 0 2024-09
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12
Xencor USD 70.02M 59.31M 2024-12



Alnylam Pharmaceuticals Försäljning - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.